{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:01:25Z","timestamp":1781010085084,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.drugalcdep.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T08:20:31Z","timestamp":1284711631000},"page":"83-85","source":"Crossref","is-referenced-by-count":28,"title":["Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere"],"prefix":"10.1016","volume":"113","author":[{"given":"Peter","family":"Vickerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.22534","article-title":"High incidence of hepatitis C virus reinfection in a cohort of injecting drug users","volume":"48","author":"Aitken","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-7622-2-9","article-title":"The epidemiological impact of antiretroviral use predicted by mathematical models: a review","volume":"2","author":"Baggaley","year":"2005","journal-title":"Emerg. Themes Epidemiol."},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2010.08.001_bib0020","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0035","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","article-title":"Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review","volume":"103","author":"Malta","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0040","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa0908014","article-title":"Telaprevir for previously treated chronic HCV infection","volume":"362","author":"McHutchison","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2009.02.014","article-title":"Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia","volume":"58","author":"Miller","year":"2009","journal-title":"J. Infect."},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0055","series-title":"Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2006"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0070","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users","volume":"102","author":"van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2010.08.001_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2010.03.006","article-title":"Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs","volume":"110","author":"Zeiler","year":"2010","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161000270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161000270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T02:50:29Z","timestamp":1544237429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161000270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":15,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S037687161000270X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.08.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}